These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29100804)

  • 1. Immunohistochemical localization of exoribonucleases (DIS3L2 and XRN1) in intranuclear inclusion body disease.
    Mori F; Tanji K; Miki Y; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2018 Jan; 662():389-394. PubMed ID: 29100804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of the exoribonucleases DIS3L2 and XRN1 in human disease.
    Pashler AL; Towler BP; Jones CI; Newbury SF
    Biochem Soc Trans; 2016 Oct; 44(5):1377-1384. PubMed ID: 27911720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.
    Mori F; Tanji K; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2013 Dec; 33(6):637-44. PubMed ID: 23782134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
    Mori F; Tanji K; Kon T; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Yoshida M; Wakabayashi K
    Neuropathol Appl Neurobiol; 2012 Jun; 38(4):322-8. PubMed ID: 21883376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy-related proteins (p62, NBR1 and LC3) in intranuclear inclusions in neurodegenerative diseases.
    Mori F; Tanji K; Odagiri S; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2012 Aug; 522(2):134-8. PubMed ID: 22728060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
    Mori F; Tanji K; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Kamitani T; Yoshida M; Wakabayashi K
    Pathol Int; 2012 Jun; 62(6):407-11. PubMed ID: 22612509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled receptor 26 immunoreactivity in intranuclear inclusions associated with polyglutamine and intranuclear inclusion body diseases.
    Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K
    Neuropathology; 2016 Feb; 36(1):50-5. PubMed ID: 26303144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases.
    Miki Y; Mori F; Kon T; Tanji K; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2014 Apr; 34(2):148-58. PubMed ID: 24313828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALS-associated protein FIG4 is localized in Pick and Lewy bodies, and also neuronal nuclear inclusions, in polyglutamine and intranuclear inclusion body diseases.
    Kon T; Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2014 Feb; 34(1):19-26. PubMed ID: 23888880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the roles of the 5' exoribonucleases Xrn1 and Xrn2 in restricting hepatitis C virus replication.
    Li Y; Yamane D; Lemon SM
    J Virol; 2015 May; 89(9):4857-65. PubMed ID: 25673723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incipient intranuclear inclusion body disease in a 78-year-old woman.
    Mori F; Miki Y; Tanji K; Ogura E; Yagihashi N; Jensen PH; Wakabayashi K
    Neuropathology; 2011 Apr; 31(2):188-93. PubMed ID: 20667015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The exoribonuclease Dis3L2 defines a novel eukaryotic RNA degradation pathway.
    Malecki M; Viegas SC; Carneiro T; Golik P; Dressaire C; Ferreira MG; Arraiano CM
    EMBO J; 2013 Jul; 32(13):1842-54. PubMed ID: 23503588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion-positive cell types in adult-onset intranuclear inclusion body disease: implications for clinical diagnosis.
    Liu Y; Mimuro M; Yoshida M; Hashizume Y; Niwa H; Miyao S; Ujihira N; Akatsu H
    Acta Neuropathol; 2008 Dec; 116(6):615-23. PubMed ID: 18923837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role for the 3'-5' exoribonuclease Dis3L2 in controlling cell proliferation and tissue growth.
    Towler BP; Jones CI; Harper KL; Waldron JA; Newbury SF
    RNA Biol; 2016 Dec; 13(12):1286-1299. PubMed ID: 27630034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture.
    Pountney DL; Raftery MJ; Chegini F; Blumbergs PC; Gai WP
    Acta Neuropathol; 2008 Dec; 116(6):603-14. PubMed ID: 18836734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of RNA decay and cellular function by 3'-5' exoribonuclease DIS3L2.
    Luan S; Luo J; Liu H; Li Z
    RNA Biol; 2019 Feb; 16(2):160-165. PubMed ID: 30638126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The exoribonuclease Xrn1 is a post-transcriptional negative regulator of autophagy.
    Delorme-Axford E; Abernathy E; Lennemann NJ; Bernard A; Ariosa A; Coyne CB; Kirkegaard K; Klionsky DJ
    Autophagy; 2018; 14(5):898-912. PubMed ID: 29465287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions.
    Seilhean D; Takahashi J; El Hachimi KH; Fujigasaki H; Lebre AS; Biancalana V; Dürr A; Salachas F; Hogenhuis J; de Thé H; Hauw JJ; Meininger V; Brice A; Duyckaerts C
    Acta Neuropathol; 2004 Jul; 108(1):81-7. PubMed ID: 15114487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5' → 3' exoribonuclease XRN1/Pacman and its functions in cellular processes and development.
    Jones CI; Zabolotskaya MV; Newbury SF
    Wiley Interdiscip Rev RNA; 2012; 3(4):455-68. PubMed ID: 22383165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optineurin in Huntington's disease intranuclear inclusions.
    Schwab C; Yu S; McGeer EG; McGeer PL
    Neurosci Lett; 2012 Jan; 506(1):149-54. PubMed ID: 22085693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.